UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

Date of Report (earliest event reported):        November 12, 2007

 

EMRISE CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

1-10346

 

77-0226211

(State or other jurisdiction of

 

(Commission

 

(I.R.S. Employer

incorporation)

 

file number)

 

Identification No.)

 

 

9485 Haven Avenue, Suite 100

Rancho Cucamonga, California 91730

(Address of principal executive offices) (Zip code)

(909) 987-9220

(Registrant’s telephone number, including area code)

Not applicable

Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 



 

Item 2.02               Results of Operations and Financial Condition

 

On November 12, 2007, EMRISE Corporation issued a press release entitled “EMRISE Corporation Announces Third Quarter 2007 Results Including Record Quarterly Sales of $12.8 Million”. A copy of the press release is attached hereto and incorporated by reference as Exhibit 99.1.

 

Item 9.01               Financial Statements and Exhibits

 

d.             Exhibits:

 

99.1                           Press Release titled “EMRISE Corporation Announces Third Quarter 2007 Results Including Record Quarterly Sales of $12.8 Million” dated November 12, 2007.

 

 

 



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

EMRISE CORPORATION

 

 

Dated: November 14, 2007

By: /s/ D. JOHN DONOVAN

 

 D. John Donovan, Vice President of Finance and  Administration (principal financial officer)

 



 

INDEX TO EXHIBITS ATTACHED TO THIS REPORT

 

Exhibit No.

                Description

99.1

Press Release titled “EMRISE Corporation Announces Third Quarter 2007 Results Including Record Quarterly Sales of $12.8 Million” dated November 12, 2007.